Medigate completes $30 million series B round to expand Tel Aviv R&D center
Medigate’s solution addresses patient safety and privacy by automatically locating, identifying, and managing the security posture of all devices connected to the network
Meir Orbach | 16:00 15.09.2020
Tel Aviv-headquartered medical cybersecurity startup Medigate Tech Ltd. has raised a $30 million series B round led by new investor Partech Partners. Previous backers YL Ventures, U.S. Venture Partners, and Blumberg Capital, as well as first time investor Maor Investments, also participated in the round. The new round brings Medigate’s total funding to around $50 million. The company, which employs 90 people, 60 of them in Israel said it would use the new capital to recruit additional employees to its Tel Aviv R&D center. As the volume and velocity of data generated from IoT and medical devices surges, healthcare organizations are expanding their digital strategies beyond their walls to include technology like wearable devices designed for patient monitoring and mobile devices used for telehealth.